ZNF605

gene
On this page

Summary

ZNF605 (zinc finger protein 605, HGNC:28068) is a protein-coding gene on chromosome 12q24.33, encoding Zinc finger protein 605 (Q86T29). May be involved in transcriptional regulation.

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.

Source: NCBI Gene 100289635 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 34 total
  • MANE Select transcript: NM_183238

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28068
Approved symbolZNF605
Namezinc finger protein 605
Location12q24.33
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000196458
Ensembl biotypeprotein_coding
Entrez100289635

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 13 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000331711, ENST00000360187, ENST00000381215, ENST00000392321, ENST00000412621, ENST00000539809, ENST00000891951, ENST00000891952, ENST00000891953, ENST00000891954, ENST00000891955, ENST00000920344, ENST00000920345, ENST00000920346, ENST00000957903, ENST00000957904, ENST00000957906

RefSeq mRNA: 2 — MANE Select: NM_183238 NM_001164715, NM_183238

CCDS: CCDS31938, CCDS53850

Canonical transcript exons

ENST00000360187 — 5 exons

ExonStartEnd
ENSE00001470908132948148132948270
ENSE00001470909132956243132956306
ENSE00002305965132918306132927162
ENSE00003493595132933035132933155
ENSE00003530841132945621132945797

Expression profiles

Bgee: expression breadth ubiquitous, 196 present calls, max score 86.49.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.6588 / max 110.6103, expressed in 1679 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1342626.65881679

Top tissues by expression

243 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534386.49gold quality
oviduct epitheliumUBERON:000480486.24gold quality
right hemisphere of cerebellumUBERON:001489083.61gold quality
tibiaUBERON:000097983.44gold quality
calcaneal tendonUBERON:000370183.29gold quality
cerebellar hemisphereUBERON:000224582.82gold quality
cerebellar cortexUBERON:000212982.65gold quality
cerebellumUBERON:000203781.87gold quality
ganglionic eminenceUBERON:000402381.83gold quality
apex of heartUBERON:000209881.59gold quality
right lobe of thyroid glandUBERON:000111981.08gold quality
thyroid glandUBERON:000204681.01gold quality
left lobe of thyroid glandUBERON:000112080.86gold quality
adrenal tissueUBERON:001830380.60gold quality
right uterine tubeUBERON:000130280.46gold quality
adenohypophysisUBERON:000219680.22gold quality
lower esophagusUBERON:001347380.07gold quality
lower esophagus muscularis layerUBERON:003583380.07gold quality
right ovaryUBERON:000211879.97gold quality
fallopian tubeUBERON:000388979.92gold quality
stromal cell of endometriumCL:000225579.91gold quality
muscle layer of sigmoid colonUBERON:003580579.85gold quality
esophagogastric junction muscularis propriaUBERON:003584179.75gold quality
left ovaryUBERON:000211979.59gold quality
pituitary glandUBERON:000000779.35gold quality
body of uterusUBERON:000985379.04gold quality
right atrium auricular regionUBERON:000663179.00gold quality
ventricular zoneUBERON:000305378.89gold quality
right adrenal glandUBERON:000123378.82gold quality
right lobe of liverUBERON:000111478.81gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-8142yes16.82
E-GEOD-137537yes5.75
E-ANND-3yes5.15
E-MTAB-6379no253.77
E-MTAB-7303no107.57

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

126 targeting ZNF605, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-569699.9872.364487
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-539-5P99.9370.302855
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-627-3P99.9071.423316
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-153-5P99.8973.866317
HSA-MIR-548D-3P99.8770.674362
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-579-3P99.8671.663628
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-221-5P99.8665.451052
HSA-MIR-807399.8665.211118
HSA-LET-7G-3P99.8570.431929
HSA-MIR-444799.8567.812900
HSA-MIR-629-3P99.8567.991875
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp605ENSMUSG00000023284
rattus_norvegicusZfp605ENSRNOG00000037428

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 605Q86T29 (reviewed: Q86T29)

All UniProt accessions (1): Q86T29

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q86T29-11yes
Q86T29-22

RefSeq proteins (2): NP_001158187, NP_899061* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (23 total): zinc finger region 17, cross-link 2, chain 1, domain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86T29-F174.050.22

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 77, 391

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 53 (showing top): CHANDRAN_METASTASIS_UP, chr12q24, CHANDRAN_METASTASIS_TOP50_UP, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, ROESSLER_LIVER_CANCER_METASTASIS_DN, CBX5_TARGET_GENES, E2F5_TARGET_GENES, ZNF197_TARGET_GENES, ZNF22_TARGET_GENES, ZNF350_TARGET_GENES, ZNF711_TARGET_GENES, ZNF766_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR579_3P, MIR664B_3P

GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
nucleic acid binding1
transition metal ion binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

438 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF605ARMCX4Q5H9R4507
ZNF605YJEFN3A6XGL0448
ZNF605SLF2Q8IX21441
ZNF605M9MMK7M9MMK7432
ZNF605NOAZFPQ9Y3S2418
ZNF605PCMTD1Q96MG8417
ZNF605LINC02881B7Z368406
ZNF605MOCOSQ96EN8398
ZNF605IGSF10Q6WRI0397
ZNF605PCDHGB4Q9UN71380
ZNF605NUDT5Q9UKK9378
ZNF605TMEM178BH3BS89372
ZNF605YIPF4Q9BSR8369
ZNF605CMYA5Q8N3K9367
ZNF605AFG2BQ9BVQ7357

IntAct

3 interactions, top by confidence:

ABTypeScore
APPZNF605psi-mi:“MI:0915”(physical association)0.000

BioGRID (2): ZNF605 (Two-hybrid), ZNF605 (Two-hybrid)

ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, A8MUV8, B4DXR9, C9JN71, O75346, O75373, O95780, P0CJ79, P0DKX0, P0DPD5, P17019, P17035, P35789, Q03923, Q03938, Q08AN1, Q14593, Q15928, Q3SXZ3, Q3ZCX4, Q5MCW4, Q5R9S5, Q5RER9, Q68DY1, Q6JLC9, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q76KX8, Q86T29, Q86V71, Q8IYN0, Q8N4W9, Q8N7M2, Q8NEM1, Q8TD23

Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

34 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1180 predictions. Top by Δscore:

VariantEffectΔscore
12:132933029:TCTTA:Tdonor_loss1.0000
12:132933030:CTTA:Cdonor_loss1.0000
12:132933031:TTA:Tdonor_loss1.0000
12:132933032:T:TGdonor_loss1.0000
12:132933033:A:ACdonor_gain1.0000
12:132933033:A:AGdonor_loss1.0000
12:132933033:AC:Adonor_gain1.0000
12:132933034:C:CCdonor_gain1.0000
12:132933034:CC:Cdonor_gain1.0000
12:132948147:CA:Cdonor_gain1.0000
12:132956241:ACC:Adonor_gain1.0000
12:132956242:CCC:Cdonor_gain1.0000
12:132928335:AAAT:Adonor_gain0.9900
12:132928336:A:Cdonor_gain0.9900
12:132928376:T:TAdonor_gain0.9900
12:132936523:T:Cacceptor_gain0.9900
12:132936525:G:Cacceptor_gain0.9900
12:132948125:T:TAdonor_gain0.9900
12:132956062:T:TAdonor_gain0.9900
12:132933153:TAT:Tacceptor_gain0.9800
12:132933153:TATC:Tacceptor_loss0.9800
12:132933154:ATC:Aacceptor_loss0.9800
12:132933155:TC:Tacceptor_loss0.9800
12:132933157:T:Gacceptor_loss0.9800
12:132933159:GAAAA:Gacceptor_loss0.9800
12:132936523:T:TCacceptor_gain0.9800
12:132948147:CACT:Cdonor_gain0.9800
12:132948187:G:Cdonor_gain0.9800
12:132956236:C:CAdonor_gain0.9800
12:132956237:CCTTA:Cdonor_loss0.9800

AlphaMissense

4300 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:132925757:A:CF514L0.997
12:132925757:A:TF514L0.997
12:132925759:A:GF514L0.997
12:132925673:A:CF542L0.996
12:132925673:A:TF542L0.996
12:132925675:A:GF542L0.996
12:132926513:G:CF262L0.996
12:132926513:G:TF262L0.996
12:132926515:A:GF262L0.996
12:132926597:A:CF234L0.996
12:132926597:A:TF234L0.996
12:132926599:A:GF234L0.996
12:132926681:A:CF206L0.996
12:132926681:A:TF206L0.996
12:132926683:A:GF206L0.996
12:132926261:G:CF346L0.995
12:132926261:G:TF346L0.995
12:132926263:A:GF346L0.995
12:132925505:G:CF598L0.994
12:132925505:G:TF598L0.994
12:132925507:A:GF598L0.994
12:132925841:G:CF486L0.994
12:132925841:G:TF486L0.994
12:132925843:A:GF486L0.994
12:132925925:G:CF458L0.994
12:132925925:G:TF458L0.994
12:132925927:A:GF458L0.994
12:132926160:A:GL380P0.994
12:132926429:G:CF290L0.994
12:132926429:G:TF290L0.994

dbSNP variants (sampled 300 via entrez): RS1000018757 (12:132934567 G>A), RS1000070213 (12:132952185 G>A,C), RS1000173422 (12:132954221 C>T), RS1000266719 (12:132954119 T>C), RS1000447676 (12:132950294 A>C), RS1000533272 (12:132929885 T>C), RS1000756595 (12:132923145 G>A), RS1000882103 (12:132950455 G>A,T), RS1000898926 (12:132946435 C>G,T), RS1000929610 (12:132946631 A>T), RS1000966164 (12:132930158 G>C), RS1001089019 (12:132941228 A>G), RS1001213753 (12:132944290 C>A,T), RS1001290106 (12:132949923 T>C), RS1001291130 (12:132940957 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST010002_179Refractive error1.000000e-12
GCST90002390_182Mean corpuscular hemoglobin6.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004527mean corpuscular hemoglobin

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression, decreases methylation, increases methylation2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Valproic Acidaffects expression, decreases expression2
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
arseniteaffects binding, decreases reaction1
sodium arsenitedecreases expression1
benzo(e)pyrenedecreases methylation1
aflatoxin B2decreases methylation1
avobenzonedecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
Sunitinibdecreases expression1
Leflunomidedecreases expression1
Arsenicaffects methylation1
Atrazinedecreases expression1
Succimerincreases expression, affects cotreatment1
Doxorubicindecreases expression1
Methapyrilenedecreases methylation1
Nicotineincreases expression1
Tetrachlorodibenzodioxindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Urethanedecreases expression1
Antirheumatic Agentsincreases expression1
Cadmium Chloridedecreases expression1
Magnetite Nanoparticlesaffects cotreatment, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.